"It is not about how much money you make. The question is are you educated enough to KEEP it."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
it's tough waiting for that climb.
way to go Daniel.
it will be nice to see the full video when it comes out like the sneak peek.
I'm ready it's time.
we are having a solid gold day!
Yield Sign is up https://www.otcmarkets.com/stock/RSHN/overview
when rshn moved up 2 weeks ago it was at 130% + and there were 15 stocks at a lower price point on the board and no rshn.
BREAKOUT BOARDS COUNT THE POSTED MESSAGES AMONG OTHER THINGS NOT A REAL TRUE INDICATOR OF MOVEMENT.
Then he plans on buying back shares its the only way if no r/s
In order to cancel shares, the company must first redeem them by paying the current price on the public stock exchange. A redemption of shares reduces the number of outstanding "issued" shares available to public investors, also known as the float.
Ok, billy I did not know that that's good to hear.
I agree 100% with your statement.
The OTC makes share count Determination as far as correctness if anything is out of place they will notify Mr. sweat and he will have to refile before stopsign is removed so far Mr. Sweat has been upfront with what's going on so he should inform us if there is a mistake and if he does not inform us that's a big red flag in my eyes. jmo
As more legitimate news drops if we can get above .0062 that seems to be the next resistence/support level and the next base. jmo
Congratulations! mine is going on 9 time flys fast hope you and your family have a blessed weekend.
you know they have world class white marlin fishing off the maui coast.
Have a blessed weekend ??
Time billy.
if I buy a house and the day before I buy someone gets murdered in it that does not make me guilty.
But accusing a new CEO that's owns RSHN of doing what you think the old owner has done has no logic at all we all agree we need to do smart DD but Mr Sweat is doing the right things at this point we should watch things and be true to what we see but by true to the above when judging a new owner.
Real RSHN due diligence courtesy of jmshort3. time to move north.
RushNet Inc. Cancellation of Proposed Reverse Split
10:30 AM ET 6/9/21 | Dow Jones
ALPHARETTA, GA / ACCESSWIRE / June 9, 2021 / RushNet, Inc. (OTC PINK:RSHN) ("RushNet") with merger/acquisition target heliosDX, is pleased to announce the official cancelation of the proposed Reverse Split (RS). The company will file with the Colorado Secretary of State to reflect such cancelation.
About HeliosDx:
heliosDX is a National Independent Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. We are contracted in 44 of the lower 48 states and looking to expand our reach and capabilities. Always staying ahead of the curve, by continually investing in our infrastructure with the most efficient scientific proven instruments, and latest cutting-edge software for patient and physician satisfaction. This allows heliosDX to provide physicians fast and accurate reporting meeting and exceeding industry benchmarks. We excel in patient and client care through physician designed panels that aid in testing compliance and reporting education.
Contact: Ashley Sweat
asweat@heliosdx.com
www.heliosdx.com (Under Development)
Twitter: @dx_helios
Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). The Companies caution that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.
Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives -
On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importance of disclosure during the COVID-19 crisis.
The SEC and Self-Regulatory Organizations are targeting public companies that claim to have products, treatment, or other strategies with regard to COVID-19.
The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Additionally, new information may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time.
We further caution investors that our primary focus and goal is to battle this pandemic for the good of the world. As such, it is possible that we may find it necessary to make disclosures which are consistent with that goal, but which may be adverse to the pecuniary interests of the Company and of its shareholders.
SOURCE: RushNet, Inc.
View source version on accesswire.com:
https://www.accesswire.com/651107/RushNet-Inc-Cancellation-of-Proposed-Reverse-Split
> Dow Jones Newswires
June 09, 2021 10:30 ET (14:30 GMT)
should be interesting.
This statement mean's no SCAM (including Ashley Sweat) of
the Company are currently under investigation by any federal or state regulatory authority for
any violation of state or federal securities laws.
its consolidating Billy.
its not called tanking its called consolidation.
same here started small nice too have you onboard for the ride.
count me in its been years in the making here with you my friend.
erupted like a volcano at 9.30 now flowing a steady stream of lava money going to penny land.
1.5 mil give or take great job Daniel and this is just the begining.
and you have a right to be my friend.
wrong they drop 3yrs financials friday now current and binding buy of another company show us where they have done that before no bs' here.
wow nice jump out of the gate.
looking real good 30min to go
primed ready too go.
at .05 i will not be rich but 3/4 of a mil is not bad. we are all smiles this morning.
wonder where the price will get too this week just got done thanking Mr Sweat he gets right back to me very impressive and transparent CEO.
heliosDX and RushNet Inc Sign Binding Letter of Intent to Acquire Laboratory and Target Additional Laboratory Acquisitions
Press Release
Alpharetta GA / Accesswire / June 7, 2021 / RushNet, Inc (OTC PINK: RSHN) ("RushNet") with merger/acquisition target heliosDX, is pleased to announce a Binding Letter of Intent by heliosdDX to acquire a privately held laboratory with $10,000,000 annual revenues processing more than 5,000 tests monthly with a capacity of 12,000 monthly UDS tests.
The acquisition further increases the National footprint of heliosDX while also reducing costs, tripling the sales force, and increasing the capacity to process substantially more testing in the UDS portfolio. Significantly, the types of tests offered by heliosDX coupled with those offered by the new facility create a more expansive combined testing capacity. It is apparent as the market continues to evolve, weshould attain an even higher sales volume and footprint to secure larger national contracts, particularly with insurance carriers and medical groups, which is critical to the long-term success of heliosDX. The acquisition wouldexpedite this process along with offering more testing options at the target labs clinic sites which are not presently available, including PCR, Allergy and PGx. Conversely, the target laboratory will expand heliosDX testing capabilities and portfolio with Oral Fluid Toxicology.
Upon closing of the acquisition, we should have combined annual revenues exceeding $16,000,000. The operational efficiencies should decrease costs and increase operating margins by 10%. Accordingly, the opportunity for growth and enhanced bottom-line is substantial. The expected revenue after a full 12 months of combined operations is estimated to be $20,000,000 to $25,000,000. Additionally, with the enhanced production capacity, heliosdDX will be able to process more than 18,000 UDS samples monthly. Upon close, heliosdDX will be processing more than 7,500 UDS samples monthly with an expected growth target of 10,000 UDS monthly. This transaction not only enhances the bottom-line, but rings in a new era of scalability for heliosDX. The expected closing timeframe for this acquisition is slated for Mid-September to Early October 2021. However, both parties are interested in expediting the closing if possible.
In addition to this acquisition, heliosDX has identified a second laboratory to acquire. This laboratory likewise offers the ability for heliosDX to further enhance its operating margin as well as sales. An expected execution of the Binding Letter of Intent with targeted laboratory is for late June to early July 2021. This lab acquisition would bring an additional 1,000,000 dollars in annual revenue. More importantly, this is a strategic acquisition for location and contracting potential.
Lastly, heliosDX continues to search the market for additional laboratories for acquisition. A third laboratory has been identified and preliminary numbers shared, but negotiations have yet to begin. An update will be provided as more information is readily available.
At this time, due to the nature of such agreement and potential of disruption, each privately held company has asked for anonymity. A combined press release will be issued by the entities when appropriate.
About HeliosDx:
Having commenced operations in 2015, HeliosDX has facilitated profit and exceptional growth each year and forecasts approximately 6,000,000 in revenue in 2021.This year we take on our third mass spectrometer, the powerful Absciex 4500, which will allow us to serve the massive needs of our clientele, which has been under strain.With the procurementof a new QuantStudio12x we now enjoy a testing capacity of 1500 Covid19 patients per day. Significantly, as the importance of covid testing diminishes, this can substitute for testing other disease states. With infectious disease testing validations being completed and coming online, we will be better positioned to serve clients, having created more robust, more reliable and more rapid testing menus for Covid19, UTI, RPP, Womens Health, STI, Nail Fungus and testing for other medical maladies. Furthermore, with the assumption of our Ion S5 GeneStudio NGS testing equipment, we are poised for the huge genetics market that is so underserved.
Contact: Chattahoochee Labs/HeliosDx
asweat@heliosdx.com
www.heliosdx.com
www.heliosdx.com (Under Development)
@dx_helios
https://www.otcmarkets.com/stock/RSHN/news/heliosDX-and-RushNet-Inc-Sign-Binding-Letter-of-Intent-to-Acquire-Laboratory-and-Target-Additional-Laboratory-Acquisitio?id=306091
Ashley Sweat is a man gfyi hope it will fly and stay up this run looking good.